We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




CACLP 2025 Unites Global Innovators in IVD Industry

By LabMedica International staff writers
Posted on 11 Mar 2025
Print article
Image: CACLP 2025 will be held 22-24 March 2025 (Photo courtesy of CACLP)
Image: CACLP 2025 will be held 22-24 March 2025 (Photo courtesy of CACLP)

CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou Grand Convention & Exhibition Center. CACLP 2025 promises to be a world-class showcase of the latest innovations, professional networking and business opportunities.

Over 1,300 exhibitors will present their cutting-edge technologies across seven major categories spanning Halls 2 to 8, with more than 60 companies launching their new products onsite. CACLP 2025 will also feature dedicated Canada and Germany Pavilions, highlighting the leading diagnostic companies and innovations from North America and Europe. Government entities, medical associations, and industry organizations from countries including Canada, Germany, India, South Korea, Switzerland, the U.K., the U.S., Vietnam and beyond will actively participate, contributing to onsite discussions, especially dozens of regulatory and product innovations roadshows in the Presentation Area of Halls 5 and 7. With professional visitors and international buyers recruited from key markets worldwide, CACLP 2025 will serve as a premier platform for global networking and cross-border collaboration.

As a hub for AI and technology advancements, Hangzhou provides the perfect backdrop for CACLP 2025, which will introduce the 1st AI and Digital Twin Technology Academic Salon, exploring the transformative role of AI in diagnostics. Additionally, onsite activities will spotlight many key industry trends, including veterinary diagnostics, global investment, and primary healthcare. The event will debut three groundbreaking forums addressing critical industry shifts. The 1st Human-to-Animal Medical Device Transition Forum, co-hosted with the East and West Small Animal Veterinary Conference, will examine how human diagnostic innovations are shaping the veterinary healthcare market, with a focus on standardization, regulations, and commercialization. The 1st National Primary Healthcare Laboratory Forum addresses quality control, test result standardization, and access to advanced diagnostics, supporting the growth of grassroots laboratory services. The 1st China IVD Companies Globalization Forum will feature insights from government officials, regulatory experts, and industry leaders, providing strategic guidance on global market trends, regulatory pathways, and international expansion.

In addition to the exhibition and newly launched activities, CACLP remains a hub for academic and industry dialogues. Further high-level conferences and forums will be primarily held in Hall 1 – the Convention Center. The 10th China Experimental Medicine Conference (CEMC), themed "A Decade Together for a Shared Future", will bring together leading academicians, hospital presidents, and experts in experimental medicine and biomedical engineering. Discussions will cover early disease screening, personalized treatment, AI integration, and other cutting-edge advancements. The conference will also feature sessions dedicated to pathology, molecular diagnostics, coagulation, mass spectrometry, and more specific topics. The 12th China IVD Industry Development Conference (CIIDC), under the theme "Empowering the Future with New Intelligence", will explore the future of the IVD industry through discussions on sustainability, international expansion, healthcare reforms, technological advancements, investment strategies, and industry development.

A key highlight will be the official release of the Annual Report of China IVD Industry 2024, providing essential insights into market performance and trends. Additional forums including Enlightening Lab Med – The 8th IVD Youth Entrepreneur Forum (ELMY), the 7th China IVD Distribution Enterprise Forum (CIDEF), and the 5th China Key Raw Material & Parts Forum (CKRMPF), will offer targeted discussions for different segments of the IVD industry. With two main tradeshows and over 100 concurrent activities, and unmatched networking opportunities, CACLP 2025 is the go-to event for professionals in diagnostics, laboratory medicine, and healthcare.

Related Links:
CACLP

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.